sb 239063 has been researched along with Colitis in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
Colitis: Inflammation of the COLON section of the large intestine (INTESTINE, LARGE), usually with symptoms such as DIARRHEA (often with blood and mucus), ABDOMINAL PAIN, and FEVER.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Santén, S | 1 |
| Mihaescu, A | 1 |
| Laschke, MW | 1 |
| Menger, MD | 1 |
| Wang, Y | 1 |
| Jeppsson, B | 1 |
| Thorlacius, H | 1 |
1 other study available for sb 239063 and Colitis
| Article | Year |
|---|---|
p38 MAPK regulates ischemia-reperfusion-induced recruitment of leukocytes in the colon.
Topics: Animals; Cell Adhesion; Colitis; Colon; Dose-Response Relationship, Drug; Endothelial Cells; Enzyme | 2009 |